Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)
- PMID: 10189040
- DOI: 10.1023/a:1008819500080
Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)
Abstract
Objectives: Recent experimental studies have suggested that isoflavones (such as genistein and daidzein) found in some soy products may reduce the risk of cancer. The purpose of this study was to evaluate the relationship between soy milk, a beverage containing isoflavones, and prostate cancer incidence.
Methods: A prospective study with 225 incident cases of prostate cancer in 12,395 California Seventh-Day Adventist men who in 1976 stated how often they drank soy milk.
Results: Frequent consumption (more than once a day) of soy milk was associated with 70 per cent reduction of the risk of prostate cancer (relative risk = 0.3, 95 percent confidence interval 0.1-1.0, p-value for linear trend = 0.03). The association was upheld when extensive adjustments were performed.
Conclusions: Our study suggests that men with high consumption of soy milk are at reduced risk of prostate cancer. Possible associations between soy bean products, isoflavones and prostate cancer risk should be further investigated.
Comment in
-
Diet and prostate cancer risk: the embarrassment of riches.Cancer Causes Control. 1998 Dec;9(6):541-3. doi: 10.1023/a:1008898918799. Cancer Causes Control. 1998. PMID: 10189038 No abstract available.
Similar articles
-
Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):538-45. doi: 10.1158/1055-9965.EPI-06-0517. Epub 2007 Mar 2. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17337648
-
Soy and isoflavone consumption and subsequent risk of prostate cancer mortality: the Japan Public Health Center-based Prospective Study.Int J Epidemiol. 2020 Oct 1;49(5):1553-1561. doi: 10.1093/ije/dyaa177. Int J Epidemiol. 2020. PMID: 32968784
-
Soy and isoflavone consumption in relation to prostate cancer risk in China.Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):665-8. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12869409
-
Soy, isoflavones, and prostate cancer.Mol Nutr Food Res. 2009 Feb;53(2):217-26. doi: 10.1002/mnfr.200800167. Mol Nutr Food Res. 2009. PMID: 18985655 Review.
-
Emerging evidence on the role of soy in reducing prostate cancer risk.Nutr Rev. 2003 Apr;61(4):117-31. doi: 10.1301/nr.2003.apr.117-131. Nutr Rev. 2003. PMID: 12795445 Review.
Cited by
-
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.Oncotarget. 2015 Mar 10;6(7):4649-62. doi: 10.18632/oncotarget.3080. Oncotarget. 2015. PMID: 25609198 Free PMC article.
-
Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.Rev Urol. 2002;4 Suppl 5(Suppl 5):S18-28. Rev Urol. 2002. PMID: 16986062 Free PMC article.
-
Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.Br J Cancer. 2009 Feb 24;100(4):649-55. doi: 10.1038/sj.bjc.6604920. Epub 2009 Feb 10. Br J Cancer. 2009. PMID: 19209173 Free PMC article.
-
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?Front Oncol. 2023 May 17;13:1196217. doi: 10.3389/fonc.2023.1196217. eCollection 2023. Front Oncol. 2023. PMID: 37265797 Free PMC article. Review.
-
Obesity and life expectancy among long-lived Black adults.J Gerontol A Biol Sci Med Sci. 2014 Jan;69(1):63-72. doi: 10.1093/gerona/glt049. Epub 2013 May 16. J Gerontol A Biol Sci Med Sci. 2014. PMID: 23682156 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical